Nektar Therapeutics (NKTR) Stock Forecast & Predictions

Nektar Therapeutics NKTR: $20.1

455 Mission Bay Blvd S, San Francisco, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web:

  • Market Cap$3.60B
  • Change (52 Weeks)1.18%
  • Low (52 Weeks)$15.39
  • Nektar Therapeutics (NKTR) Forecast Based on Technical Analysis

    Based on 16 Technical Indicators where 18.75% are on Buy, 31.25% on Sell, and 50.00% Neutral.

    According to the market data, Nektar Therapeutics (NKTR) stock price is $20.1 and the 52 weeks low is $15.39, which means the Nektar Therapeutics stock price is up 1.18% in the last 12 months.

    Nektar Therapeutics (NKTR) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 18.75% are indicating that NKTR Stock price might rise further, 31.25% indicating that NKTR Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall NKTR stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Nektar Therapeutics (NKTR) Stock Forecast By Analysts

    On Hold
    Analysts Recommendations for Nektar Therapeutics (NKTR) is based on 20 Institutional Analyst Ratings where 35.00% are on Strong Buy, 20.00% on Moderate Buy, 45.00% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 20 Institutional Analysts, majority recommended NKTR stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Nektar Therapeutics.

    Nektar Therapeutics (NKTR) Stock Price Prediction By Analysts

    $31.9358.84% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for NKTR set by the institutional analysts is $31.93 where High Estimate is $84.00, Median $26.01 and Low $20.20.

    The average price target for NKTR by Institutional Analysts is $31.93, which is 58.84% Upside from the current price. So according to the Institutional Analysts, NKTR Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Nektar Therapeutics (NKTR) Stock Forecasts By Institutional Analysts

    SVB LeerinkMarket PerformMaintained
    SVB LeerinkMarket PerformMaintained
    SVB LeerinkMarket PerformMaintained
    HC Wainwright & Co.NeutralReiterated
    SVB LeerinkMarket PerformMaintained
    Goldman SachsNeutralUpgraded
    JP MorganNeutralMaintained
    JP MorganNeutralMaintained
    Canaccord GenuityBuyMaintained
    H.C. WainwrightNeutralMaintained
    Piper JaffrayOverweightMaintained
    Goldman SachsSellDowngraded
    JP MorganNeutralDowngraded
    BMO CapitalOutperformMaintained
    BMO CapitalOutperformInitiated
    Goldman SachsBuyInitiated
    Canaccord GenuityBuyMaintained
    H.C. WainwrightNeutralDowngraded
    JP MorganOverweightMaintained
    Seaport GlobalBuyInitiated
    Canaccord GenuityBuyMaintained
    Canaccord GenuityBuyInitiated
    Cowen & Co.OutperformInitiated
    H.C. WainwrightBuyInitiated
    Aegis CapitalBuyInitiated
    Janney CapitalBuyInitiated
    JP MorganOverweightMaintained
    Bank of AmericaUnderperformMaintained
    Brean CapitalBuyMaintained
    Ladenburg ThalmannBuyInitiated
    MKM PartnersNeutralDowngraded
    Brean CapitalBuyMaintained
    Cowen & Co.OutperformInitiated
    Deutsche BankBuyMaintained
    Bank of AmericaUnderperformMaintained
    Deutsche BankBuyMaintained
    Bank ofericaUnderperformDowngraded

    Nektar Therapeutics (NKTR) Stock Earning Per Share (EPS) Forecast / Estimate

    The average consensus EPS for NKTR is $-0.756 with a high estimate of $-0.651 and Low of $-0.813 for the period 2021-06-30 and based on 13 Institutional Analysts.

    Last Quarter


    The latest average Earning Per Share Estimate for Nektar Therapeutics is $-0.76, which is lower than NKTR's last EPS, $-0.61. This means that Analysts are expecting Nektar Therapeutics to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Nektar Therapeutics.

    Earning Per Share (EPS) History


    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).